Skip to main content

Table 1 Characteristics of non-DM patients with ACS undergoing PCI with or without major adverse cardiac events (MACEs)

From: Adjustment of the GRACE score by HemoglobinA1c enables a more accurate prediction of long-term major adverse cardiac events in acute coronary syndrome without diabetes undergoing percutaneous coronary intervention

Variable

All patients (n = 533)

With MACE (n = 69)

Without MACE (n = 464)

p value

Age (year)

59.96 ± 12.65

64.58 ± 11.43

59.27 ± 12.69

0.001

Sex

 Male

361 (67.7)

47 (68.1)

314 (67.7)

0.941

BMI (kg/m2)

24.11 ± 2.70

24.60 ± 2.96

24.04 ± 2.65

0.111

Hypertension

195 (36.6)

40 (58.0)

155 (33.4)

<0.001

Smoking

333 (62.5)

48 (69.6)

285 (61.4)

0.192

Prior MI

37 (6.9)

13 (18.8)

24 (5.2)

<0.001

Prior PCI

24 (4.5)

7 (10.1)

17(3.7)

0.015

DBP (mmHg)

77.94 ± 13.00

77.88 ± 12.40

77.95 ± 13.11

0.967

SBP (mmHg)

125.53 ± 20.02

126.35 ± 21.78

125.41 ± 19.77

0.716

Heart rate (bpm)

75.36 ± 13.27

77.12 ± 13.50

75.10 ± 13.24

0.240

eGFR (mL min−1 1.73 m−2)

88.60 ± 35.50

87.05 ± 37.31

88.83 ± 35.26

0.697

FBS (mmol/L)

6.37 ± 1.82

6.28 ± 1.35

6.39 ± 1.88

0.652

TC (mmol/L)

3.92 ± 1.08

3.94 ± 0.92

3.92 ± 1.10

0.926

TG (mmol/L)

1.62 ± 1.00

1.47 ± 1.07

1.65 ± 0.99

0.171

HDL (mmol/L)

1.02 ± 0.25

1.04 ± 0.26

1.02 ± 0.25

0.541

LDL (mmol/L)

2.28 ± 0.74

2.30 ± 0.75

2.27 ± 0.74

0.774

Apo A1 (g/L)

1.08 ± 0.18

1.08 ± 0.22

1. 08 ± 0.18

0.894

Apo B (g/L)

0.77 ± 0.23

0.76 ± 0.22

0.77 ± 0.23

0.904

LVEF (%)

54.26 ± 12.34

49.68 ± 12.23

54.94 ± 12.15

0.001

NT-proBNP (pg/mL)

5.86 ± 1.60

6.30 ± 1.82

5.79 ± 1.56

0.013

PLT count (109/L)

192.81 ± 68.17

212.67 ± 82.73

189.86 ± 65.32

0.009

WBC count (109/L)

8.05 ± 3.23

8.38 ± 3.56

8.00 ± 3.18

0.366

Monocyte count (109/L)

0.57 ± 0.32

0.65 ± 0.45

0.55 ± 0.30

0.021

Neutrophile count (109/L)

5.92 ± 3.14

6.36 ± 3.21

5.85 ± 3.13

0.213

HbA1c content (%)

5.60 ± 0.46

5.90 ± 0.33

5.56 ± 0.46

<0.001

GRACE score

110.47 ± 27.13

131.45 ± 24.40

107.35 ± 26.13

<0.001

Medication at discharge

 Aspirin

524 (98.3)

66 (95.7)

458 (98.7)

0.066

 Clopidogrel

527 (98.9)

68 (98.5)

459 (98.9)

0.785

 Statins

430 (80.7)

58 (84.1)

372 (80.2)

0.446

 ACEI/ARB

389 (73.0)

46 (66.7)

343 (73.9)

0.205

 β-blockers

347 (65.1)

42 (60.9)

305 (65.7)

0.429

  1. Data are mean ± SD or n (%)
  2. BMI body mass index, Prior MI prior myocardial infarction, Prior PCI prior percutaneous coronary intervention, SBP systolic blood pressure, DBP diastolic blood pressure, eGFR estimated glomerular filtration rate, FBS fasting blood sugar, TC total cholesterol, TG triglycerides, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, Apo-A1 apolipoprotein A1, Apo-B apolipoprotein B, NT-proBNP N-terminal pro-B-type natriuretic peptide, PLT platelets, LVEF left ventricle ejection fraction, WBC white blood cell count, ACEI angiotensin-converting enzyme inhibition, ARB angiotensin receptor blocker, HbA1c hemoglobin A1c, GRACE score Global Registry of Acute Coronary Events (GRACE) score
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840